# Myongji Hospital

Organization · id `cardio:org-myongji-hospital` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 03zn16x61](<https://ror.org/03zn16x61>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 03zn16x61 by an exact name.

## The registry's words

- Sponsor name: Myongji Hospital
- Sponsor class: OTHER
- ROR name: Myongji Hospital

## Connected pages

- Sponsors: Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic Patients (`cardio:ct-nct01382303`)
- Sponsors: Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke (`cardio:ct-nct03993236`)
- Sponsors: Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy (`cardio:ct-nct07796217`)

## Provenance

Content hash: 976859c2d91f9b235c736aaf85122cc615f203121e4121de364df8cc219ceb94
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
